Red Flags Detected
- Going Concern (new) — Company now discloses substantial doubt about ability to continue operations due to insufficient cash to fund operations through the next 12 months.
- Delisting (new) — Company received Nasdaq deficiency notice for failing to maintain minimum $1.00 bid price and has until August 17, 2026 to regain compliance or face delisting.
- Securities Litigation (worsened) — Partial dismissal with prejudice indicates some claims survived and litigation continues with a third amended complaint.
Outlook Therapeutics flags going concern, misses debt payment, faces Nasdaq delisting
Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade OTLK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 27, 2026 5:05 PM